A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery-Reference-Cited by-同舟云学术

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

Published:2021-08 Issue:4 Volume:6 Page:100209
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Pautier P.,Floquet A.,Chevreau C.,Penel N.,Guillemet C.,Delcambre C.,Cupissol D.,Selle F.,Isambert N.,Piperno-Neumann S.,Saada-Bouzid E.,Bertucci F.,Bompas E.,Alexandre J.,Collard O.,Lebrun-Ly V.,Soulier P.,Toulmonde M.,Le Cesne A.,Lacas B.,Duffaud F.

Funder

PharmaMar SA

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing;Ducimetière;PLoS One,2011

2. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network;de Pinieux;PLoS One,2021

3. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial;Judson;Lancet Oncol,2014

4. Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group

5. Differential gene expression in leiomyosarcoma;Skubitz;Cancer,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blue marine therapy: Sea as a trove of natural anticancer drugs;Annales Pharmaceutiques Françaises;2023-11

2. Nanomaterials as an advanced nano-tool for the Doxorubicin delivery/ Co-Delivery—A Comprehensive Review;Journal of Drug Delivery Science and Technology;2023-05

3. Evaluation of the efficacy of systemic therapy for advanced uterine leiomyosarcoma: A systematic review, meta‐analysis, and meta‐regression analysis;Cancer Medicine;2023-04-20

4. The biology and treatment of leiomyosarcomas;Critical Reviews in Oncology/Hematology;2023-04

5. Targeting the Molecular and Immunologic Features of Leiomyosarcoma;Cancers;2023-03-31